CVS Health to hold second quarter 2025 earnings conference call
CVS Health (NYSE: CVS) announced it will host its second quarter 2025 earnings conference call on Thursday, July 31st, 2025, at 8:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CVS Health (NYSE: CVS) announced it will host its second quarter 2025 earnings conference call on Thursday, July 31st, 2025, at 8:00 a.m. ET. During the call, management will discuss the company's Q2 2025 financial results with analysts and investors. The event will be accessible via audio webcast on the Investor Relations section of the CVS Health website at investors.cvshealth.com, where the recording will remain available for one year.
Details
News Market Reaction – CVS
The recorded move for CVS in the trading session of this news was +0.72%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.
About CVS Health
CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of March 31, 2025, the Company had more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 88 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Media contact
Ethan Slavin
860-273-6095
SlavinE@cvshealth.com
Investor contact
Larry McGrath
800-201-0938
investorinfo@cvshealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-to-hold-second-quarter-2025-earnings-conference-call-302488691.html
SOURCE CVS Health
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.